Symptoms
Common signs and symptoms of Antiphospholipid Syndrome include:
When to see a doctor
If you experience severe or worsening symptoms, seek immediate medical attention. Always consult with a healthcare professional for proper diagnosis and treatment.
Causes & Risk Factors
Several factors can contribute to Antiphospholipid Syndrome.
The exact trigger that causes antiphospholipid syndrome remains unclear, but researchers understand the basic mechanism behind the condition.
The exact trigger that causes antiphospholipid syndrome remains unclear, but researchers understand the basic mechanism behind the condition. The immune system produces antibodies that mistakenly target phospholipids, which are essential components of cell membranes throughout the body. These rogue antibodies interfere with normal blood clotting processes and can damage blood vessels.
Genetic factors likely play a role, as the condition sometimes runs in families and certain genetic markers appear more frequently in affected individuals.
Genetic factors likely play a role, as the condition sometimes runs in families and certain genetic markers appear more frequently in affected individuals. However, having these genetic predispositions doesn't guarantee someone will develop the syndrome. Environmental triggers such as infections, certain medications, or other illnesses may activate the autoimmune response in genetically susceptible people.
The syndrome can develop as a primary condition on its own, or as a secondary condition alongside other autoimmune diseases, particularly systemic lupus erythematosus.
The syndrome can develop as a primary condition on its own, or as a secondary condition alongside other autoimmune diseases, particularly systemic lupus erythematosus. When it occurs with lupus, the two conditions can amplify each other's effects, leading to more complex symptoms and treatment challenges.
Risk Factors
- Having systemic lupus erythematosus or other autoimmune diseases
- Being female, especially during reproductive years
- Family history of autoimmune conditions
- Previous blood clots or pregnancy complications
- Certain genetic markers (HLA-DR7, HLA-DQB1)
- Recent infections, particularly viral illnesses
- Taking certain medications like hydralazine or procainamide
- Smoking cigarettes
- Using birth control pills or hormone therapy
- Having other risk factors for blood clots
Diagnosis
How healthcare professionals diagnose Antiphospholipid Syndrome:
- 1
Diagnosing antiphospholipid syndrome requires a combination of clinical symptoms and specific laboratory tests.
Diagnosing antiphospholipid syndrome requires a combination of clinical symptoms and specific laboratory tests. Doctors typically suspect the condition when someone experiences unexplained blood clots, recurrent pregnancy loss, or stroke-like symptoms at a young age. The diagnostic process often begins with a detailed medical history and physical examination to identify characteristic symptoms and rule out other conditions.
- 2
Laboratory testing forms the cornerstone of diagnosis, focusing on three main types of antiphospholipid antibodies: lupus anticoagulant, anticardiolipin antibodies, and anti-beta2 glycoprotein I antibodies.
Laboratory testing forms the cornerstone of diagnosis, focusing on three main types of antiphospholipid antibodies: lupus anticoagulant, anticardiolipin antibodies, and anti-beta2 glycoprotein I antibodies. These tests must be positive on two separate occasions at least 12 weeks apart to confirm the diagnosis. Additional blood tests may include complete blood count, liver function tests, and screening for other autoimmune conditions.
- 3
The diagnostic criteria require both clinical evidence (such as blood clots or pregnancy complications) and persistent positive antibody tests.
The diagnostic criteria require both clinical evidence (such as blood clots or pregnancy complications) and persistent positive antibody tests. Since these antibodies can appear temporarily during infections or with certain medications, the waiting period between tests helps ensure the antibodies represent a true autoimmune condition rather than a temporary response to illness.
Complications
- Blood clots represent the most serious immediate complication of antiphospholipid syndrome.
- These can occur in arteries or veins throughout the body, potentially causing stroke, heart attack, pulmonary embolism, or deep vein thrombosis.
- The location and severity of clots determine the specific health impacts, which can range from temporary symptoms to permanent disability or life-threatening emergencies.
- Pregnancy complications affect many women with the syndrome, including recurrent miscarriage, preeclampsia, premature delivery, and growth restriction in the developing baby.
- However, with proper treatment and monitoring, many women with antiphospholipid syndrome can have successful pregnancies.
- Long-term complications may include chronic kidney disease, heart valve damage, cognitive problems, and an increased risk of early heart disease, though these serious outcomes are less common with appropriate ongoing medical care.
Prevention
- Taking prescribed medications exactly as directed
- Attending regular medical monitoring appointments
- Recognizing early warning signs of blood clots
- Managing other cardiovascular risk factors like high blood pressure and diabetes
- Staying hydrated and mobile during travel or periods of bed rest
Treatment for antiphospholipid syndrome focuses primarily on preventing blood clots through anticoagulation therapy.
Treatment for antiphospholipid syndrome focuses primarily on preventing blood clots through anticoagulation therapy. Most people with confirmed syndrome and a history of blood clots require long-term blood thinning medication, typically warfarin or one of the newer direct oral anticoagulants. The choice of medication depends on individual factors including other health conditions, pregnancy plans, and personal preferences regarding monitoring requirements.
For people with antiphospholipid antibodies but no history of clots, treatment decisions become more individualized.
For people with antiphospholipid antibodies but no history of clots, treatment decisions become more individualized. Low-dose aspirin may be recommended, particularly for those with additional risk factors or during pregnancy. Pregnant women with the syndrome often require combination therapy with heparin injections and low-dose aspirin to prevent pregnancy complications and protect both mother and baby.
Lifestyle modifications play an important supporting role in treatment.
Lifestyle modifications play an important supporting role in treatment. Patients should avoid smoking, limit alcohol consumption, maintain a healthy weight, and stay physically active within their capabilities. Women may need to avoid estrogen-containing birth control pills and discuss safer contraceptive options with their healthcare providers. During periods of increased clot risk, such as surgery or prolonged immobility, temporary adjustments to anticoagulation may be necessary.
Emerging treatments show promise for the future.
Emerging treatments show promise for the future. Researchers are investigating targeted therapies that could address the underlying autoimmune process rather than just preventing clots. Rituximab and other immunosuppressive medications may be considered for severe cases that don't respond well to standard anticoagulation, though these approaches require careful consideration of risks and benefits.
Living With Antiphospholipid Syndrome
Living successfully with antiphospholipid syndrome requires developing a partnership with your healthcare team and learning to balance caution with maintaining quality of life. Regular medical monitoring becomes part of your routine, including blood tests to check clotting function if you're taking anticoagulants. Many people find it helpful to keep a medical alert card or wear identification jewelry indicating their condition and medications, especially since bleeding complications can occur with blood thinners.
Latest Medical Developments
Latest medical developments are being researched.
Frequently Asked Questions
Update History
Apr 4, 2026v1.0.0
- Published by DiseaseDirectory